… a short review of the drugs used and under investigation for the treatment of COVID-19. …
According to this proposal, COVID-19 would have an initial phase dominated by viral replication …

… The effectiveness of the controversial treatment options for COVID-19 … “coronavirus drug
therapy,” passive immunotherapy for … The main limiting aspects of this comprehensive review …

… would impact the clinical outcome of COVID-19, as well as other co-… -I immunotherapy for
COVID-19 patients with divergent disease severity and other co-existing conditions. This review …

… Allergen-specific immunotherapy entails administering an … Allergen injection immunotherapy
induces T cell tolerance … -term use has indicated that immunotherapy can help to avoid the …

… takes place in patients receiving immunotherapy or haploidentical allogeneic hematopoietic
… In the pathogenesis of T-cell-engaging immunotherapy, released INF-γ by activated T cells …

… The strategy we propose is typical of immunotherapy, inspired by analogue models in
cancer treatment, in this case of the NKG2A/HLA-E checkpoint blocking, which seems very …

… in the month prior to developing COVID-19. Maybe, this could simply be due … immunotherapy
are less prone to develop COVID-19 or to be admitted in hospital due to severe coronavirus …

… immunotherapy who developed longitudinal extensive transverse myelitis (LETM) after
administration of second dose of COVID-19 … the second dose of COVID-19 vaccination in a …

… coronavirus-2 (SARS-CoV-2) is a novel coronavirus that is responsible for the 2019–2020
pandemic. In this comprehensive review, … is a classic adaptive immunotherapy that has been …

… In patients with severe COVID-19, eosinopenia and … COVID-19 severity hinges on the
development of cytokine … due to COVID-19 could provide potential targets for immunotherapy and …